Overview

The Effect of Sponge Versus No-Sponge Placement of Mitomycin-C on the Outcomes of Trabeculectomy With Ex-PRESS Glaucoma Filtration Device

Status:
Completed
Trial end date:
2017-01-17
Target enrollment:
0
Participant gender:
All
Summary
The primary focus of this study is to assess intraocular pressure and complication rates between patients who receive mitomycin-C using a sponge versus no-sponge.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Duke University
Treatments:
Mitomycin
Mitomycins
Criteria
Inclusion Criteria:

1. Men or women aged 18 years and older at screening.

2. Diagnosis of chronic angle-closure glaucoma or open-angle glaucoma, phakic or
pseudophakic, with visual field or optic disc changes characteristic of glaucoma.

3. Suitable candidate for trabeculectomy with Ex-PRESS glaucoma filtration device with
MMC in the superonasal quadrant in the study eye which the physician deems as
medically necessary.

4. Capable and willing to provide consent

Exclusion Criteria:

1. Unable or unwilling to provide consent

2. Any previous ocular surgeries in the study eye preventing placement of the
trabeculectomy with Ex-PRESS glaucoma filtration device with mitomycin-C in the
superonasal quadrant

3. Any previous glaucoma drainage devices in the study eye

4. Any abnormality other than glaucoma in the study eye that could affect applanation
tonometry.

5. Presence or history of any abnormality or disorder that could interfere with the study
procedure or prevent the successful completion of the study.

6. Presence or history of uveitis within 10 years or any other ocular infection or
inflammation within 14 days before day 1.

7. Any significant unstable cardiovascular, hepatic, renal, respiratory,
gastrointestinal, endocrine, immunologic, dermatologic, hematologic, neurologic, or
psychiatric disease.

8. Known Pregnancy or Breastfeeding

Physical and Laboratory Findings

9. Conjunctival scarring precluding a superonasal implantation location.

10. Vitreous in the anterior chamber.

11. Abnormality preventing reliable applanation tonometry in the study eye.